Yale Technologies
Yale Ventures oversees Yale's technology transfer office, protecting and licensing the intellectual property developed at Yale, and helping to bring breakthroughs to market as products and services that can make a difference in the world.
Yale Technologies Available for Licensing
Yale Principal Investigator Pitches and Presentations
Search (Pitches)
Search (Pitches)
-
Biosafe SARS-CoV-2 Replicons for High-Throughput Screening
Brett Lindenbach, PhD -
Sarxion Biologics: Engineering Materials for Regenerative Medicine
Themis Kyriakides, PhD -
Miso Therapeutics
Vignesh Gunasekharan, PhD -
Discovery and Optimization of Novel Compounds Targeting Programmed Ribosomal Frameshifting in RNA Viruses
Junjie Guo, PhD -
Pastorus: Developing the First Drug for Core Symptoms of Autism
Steve W. C. Chang, PhD -
Development of camostat-related compounds for COVID-19 and other coronavirus infections
Joseph Vinetz, MD, FACP, FIDSA, FASTMH, BS -
-
Direct intralesional mTOR inhibition for targeted treatment of sporadic and syndromic venous and lymphatic malformations
Naiem Nassiri, MD, RPVI -
Stilbene a new antibiotic class for topical and systemic administration
Jason Crawford, PhD, Associate Professor of Chemistry and Associate Professor of Microbial Pathogenesis -
Fyn & Pyk2 Kinase Inhibition for Alzheimer's Disease
Stephen Strittmatter, M.D., Ph.D.